James H. Sabry, Executive Chairman at CYTOKINETICS INC (CYTK), sold 7,000 shares at $5.70 ($40K) on 2007-07-02, disclosed to the SEC on 2007-07-03.
Scheduled sale ($40k) by Executive Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.70 | 6,800 | $39K | 97.1% |
| 2 | $5.72 | 200 | $1K | 2.9% |
| Total | $5.70 avg | 7,000 | $40K | 100% |
| Filing → |
| CYTK | SELL | 2010-05-14 | $30K | — | Filing → |
| CYTK | SELL | 2010-04-28 | $32K | — | Filing → |
| CYTK | SELL | 2010-04-01 | $32K | — | Filing → |